GleamWall
中文EN

CL COLGATE PALMOLIVE CO

Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 21665 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.9%
TTM net income YoY-29.4%
TTM EPS YoY-28.0%
Revenue 3-yr CAGR3.6%
Net income 3-yr CAGR9.0%

Margins

Gross margin60.6%
Operating margin14.8%
Net margin9.6%
FCF margin17.8%
EBITDA margin17.9%

Returns

ROE358.9%
ROA12.0%
ROIC (approx.)36.1%
Asset turnover1.24x

Leverage & solvency

Liabilities / assets96.2%
Debt / equity24.94x
Current ratio0.96x
Interest coverage12.64x

Cash quality & payout

Operating cash flow / net income2.13x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue2.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$20.38B$20.10B$19.46B$17.97B$17.42B
Cost of revenue$8.13B$7.94B$8.13B$7.72B$7.05B
Gross profit$12.25B$12.16B$11.33B$10.25B$10.38B
R&D expense$366.00M$355.00M$343.00M$320.00M$307.00M
SG&A expense$7.90B$7.73B$7.15B$6.57B$6.41B
Operating income$3.31B$4.27B$3.98B$2.89B$3.33B
Interest expense$267.00M$292.00M$287.00M$167.00M$120.00M
Pretax income$3.06B$3.96B$3.39B$2.66B$3.09B
Income tax$798.00M$907.00M$937.00M$693.00M$749.00M
Net income$2.13B$2.89B$2.30B$1.78B$2.17B
EBITDA$3.94B$4.87B$4.55B$3.44B$3.89B
EPS (basic)2.643.532.782.132.56
EPS (diluted)2.633.512.772.132.55
Dividends declared per share2.082.481.911.861.79
Weighted avg. shares (diluted)811.10M823.20M829.20M838.80M848.30M
Balance sheet
Cash & equivalents$1.29B$1.10B$966.00M$775.00M$832.00M
Short-term investments$107.00M$160.00M$179.00M——
Receivables$1.68B$1.52B$1.59B$1.50B$1.30B
Inventory$2.03B$1.99B$1.93B$2.07B$1.69B
Current assets$5.71B$5.32B$5.28B$5.11B$4.40B
PP&E, net$4.66B$4.42B$4.58B$4.31B$3.73B
Goodwill$3.12B$3.27B$3.41B$3.35B$3.28B
Intangibles$1.54B$1.76B$1.89B$1.92B$2.46B
Total assets$16.33B$16.05B$16.39B$15.73B$15.04B
Current liabilities$6.85B$5.76B$4.74B$4.00B$4.05B
Short-term debt$1.11B$652.00M$20.00M$14.00M$12.00M
Long-term debt$6.87B$7.29B$8.22B$8.74B$7.19B
Total debt$7.99B$7.94B$8.24B$8.76B$7.21B
Total liabilities$15.96B$15.50B$15.44B$14.93B$14.07B
Shareholders' equity$54.00M$212.00M$609.00M$401.00M$609.00M
Net debt$6.70B$6.84B$7.27B$7.98B$6.37B
Shares outstanding801.24M812.57M821.41M830.21M840.48M
Cash flow statement
Operating cash flow$4.20B$4.11B$3.75B$2.56B$3.33B
Capital expenditure$564.00M$561.00M$705.00M$696.00M$567.00M
Free cash flow$3.63B$3.55B$3.04B$1.86B$2.76B
Investing cash flow-$817.00M-$534.00M-$742.00M-$1.60B-$592.00M
Financing cash flow-$3.26B-$3.39B-$2.79B-$952.00M-$2.77B
Depreciation & amortization$630.00M$605.00M$567.00M$545.00M$556.00M
Stock-based compensation$155.00M$135.00M$122.00M$125.00M$135.00M
Share buybacks$1.21B$1.74B$1.13B$1.31B$1.32B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.